S0027: Vinorelbine Followed by Docetaxel in Treating Patients With Advanced Non-Small Cell Lung Cancer

This study has been completed.
Sponsor:
Collaborator:
Information provided by (Responsible Party):
Southwest Oncology Group
ClinicalTrials.gov Identifier:
NCT00026156
First received: November 9, 2001
Last updated: February 12, 2013
Last verified: February 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: November 2008
  Primary Completion Date: July 2004 (Final data collection date for primary outcome measure)
Publications:
Hesketh PJ, Lilenbaum R, Chansky K, et al.: Chemotherapy in patients > 80 with advanced non small cell lung cancer: combined results from SWOG 0027 and LUN 6. [Abstract] J Clin Oncol 23 (Suppl 16): A-7147, 657s, 2005.
Hesketh PJ, Chansky K, Lau DH, et al.: Sequential vinorelbine (V) and docetaxel (D) in advanced non-small cell lung cancer (NSCLC) patients age > 70, or with performance status (PS) 2: a SWOG phase II trial (S0027). [Abstract] J Clin Oncol 22 (Suppl 14): A-7056, 630s, 2004.